-Net portfolio fair value reduction of£ 36.7 m, approximately 3%. -Oxford Nanopore more than doubled revenue and orders in 2018 to $43.7 m and $60.6 m respectively and this year opened a new factory to support rapid growth in demand for nanopore sequencing technology. -Ceres Power and Japan's Miura announced a first fuel cell product launch using Ceres technology.
RNS Number: 6316 H IP Group PLC 01 August 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
IP Group Plc (IPO.L) Announced that portfolio company Istesso Limited ("Istesso") has announced positive headline results from its Phase 2a study of its investigational drug, MBS2320, for the treatment of rheumatoid arthritis ("RA"). The study was a randomised, double-blind, placebo-controlled trial for which the primary objective was to assess the safety and tolerability of MBS2320 over 12 weeks of treatment in patients receiving background methotrexate therapy. IP Group holds a direct undiluted beneficial stake of 56.4% in Istesso and is currently reviewing the carrying value of this asset as part of its half-year results process. Separately, the company announced that portfolio company Ceres Power Holdings plc ("Ceres", "Ceres Power" or "the Company") and Doosan Corporation ("Doosan"), have signed a collaboration and licensing agreement to jointly develop SOFC distributed power systems initially targeted at the Korean commercial building market. The £8 million agreement is over two years and includes licencing, technology transfer and engineering services (subject to attainment of key milestones).
The £8 million agreement is over two years and includes licencing, technology transfer and engineering services. Dr Robert Trezona, Head of Cleantech at IP Group, said: "We're delighted to see Ceres Power go from strength to strength, adding another major partner, South Korea's Doosan, to an already impressive list of blue chip partners such as Bosch and Weichai.
RNS Number: 4544 F IP Group PLC 15 July 2019. IP Group plc- Portfolio company Istesso announces positive outcome from Phase 2 a study of MBS2320. THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION NO.596/2014..
RNS Number: 4544 F IP Group PLC 15 July 2019. IP Group plc- Portfolio company Istesso announces positive outcome from Phase 2 a study of MBS2320. THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION NO.596/2014..
RNS Number: 9434 E IP Group PLC 09 July 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
IP Group Plc (IPO.L) Announced the appointment of Aedhmar Hynes as an independent Non-executive Director with effect from 1 August 2019.
RNS Number: 0044 C IP Group PLC 13 June 2019. Hynes was Chief Executive Officer of Text100, a digital communications agency with 22 offices and over 600 consultants across Europe, North America and Asia. She is on the US Foundation Board of the National University of Ireland, Galway and is a Henry Crown Fellow at The Aspen Institute..
RNS Number: 5893 B IP Group PLC 07 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5626 B IP Group PLC 07 June 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3881 A IP Group PLC 28 May 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3864 A IP Group PLC 28 May 2019. IP Group plc- Results of Annual General Meeting. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3410 A IP Group PLC 28 May 2019. IP Group plc- Appointment of Caroline Brown as Non-executive Director. She holds a First Class degree and PhD in Natural Sciences from the University of Cambridge, a Masters of Business Administration from the Cass Business School, London and is a Fellow of the Chartered Institute of Management Accountants..
RNS Number: 3354 Z IP Group PLC 16 May 2019. IP Group plc- Withdrawal of resolution from 2019 AGM. IP Group plc, the developer of intellectual property-based businesses, notes that it is withdrawing Resolution 20, to approve amendments to the LTIP, from its AGM..
RNS Number: 0217 Y IP Group PLC 03 May 2019. IP Group plc- Appointment of corporate broker. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 3145 X IP Group PLC 26 April 2019. IP Group plc- LTIP& DBSP awards; exercise of DBSP options. IP Group made conditional awards of 5,627,936 ordinary shares of two pence each to its executive directors, other persons discharging managerial responsibilities and certain other employees under its Long-Term Incentive Plan on 25 April 2019..
RNS Number: 6761 W IP Group PLC 18 April 2019. IP Group plc- Notice of AGM; Annual Report. The 2019 Annual General Meeting will be held at 11.30 am on Tuesday 28 May 2019 at the Company's offices at The Walbrook Building, 25 Walbrook, London, EC4N 8 AF..
RNS Number: 8760 V IP Group PLC 11 April 2019. IP Group plc- Portfolio company Diurnal announces positive scientific advice from European Medicines Agency for Chronocort ®. This supports IP Group's view that the chances of approval of Chronocort in Europe are very good and, moreover, that there remains the potential for Orphan status, which would give...
IP Group Plc (IPO.L) Announced, in its annual financial results for the year ended 31 December 2018, that its fair value of portfolio stood at £1,128.20 million. Net portfolio loss stood at £48.40 million. Gross cash and deposits stood at £219.00 million. Further, the company reported that capital provided by IP Group to portfolio companies and projects stood at £100.90 million.
IP Group Plc
IPO.L
IP Group Plc
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    1.06B

Company Profile

IP Group was set up with a mission to evolve great ideas, mainly from our partner universities, into world-changing businesses. We achieve this by systematically helping to create, build and support outstanding intellectual property-based companies. The Group pioneered the concept of the long-term partnership model with UK universities and has spent many years honing a unique approach to building businesses and providing support along the journey from “cradle to maturity”. We have replicated this approach with a select group of US research institutions and, in 2017, the Group announced it was expanding into Australasia.

Classification

Market Indices-

Locations

HQ
Top Floor
The Walbrook Building
25 Walbrook
London
EC4N 8AF
Watchlist